BioSpace News Archive

BioMidwest

Sold-Out Broadway Belts For PFF! Raises Record-Breaking $350,000 For Fight Against Pulmonary Fibrosis

8th Annual Benefit hosted by Julie Halston Reunited Original HAIRSPRAY Cast Members Honor Producer Margo Lion

March 20, 2018
·
3 min read
Deals

Notification That All Shares of Hakushindo Pharmaceutical Have Been Acquired by Shinkowa Pharmaceutical Co., Ltd., the First Company in the World to Sell NMN Compound Supplements

Toward the Realization of Academic-industry Integration For True Anti-aging Medicine (Rejuvenation Research)!

March 20, 2018
·
4 min read
FDA

Life Spine Announces FDA Clearance of PLATEAU®-LO Insert and Rotate Spacer System

Life Spine, a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spinal disorders, announced today that the U.S. Food and Drug Administration (FDA) has given 510(k) marketing clearance to the PLATEAU-LO Insert and Rotate Spacer System.

March 20, 2018
·
1 min read
Pharm Country

OncLive® to Host Webinar on Emerging Strategies for Treatment of BRCA-Mutated Breast Cancer

Featured faculty will deliver latest updates in the management of breast cancer

March 20, 2018
·
2 min read
Business

MellingMedical Awarded Federal Supply Contract for Pharmaceuticals

Expanding Business to Enhance Access and Care to Pharmaceutical Products

March 20, 2018
·
1 min read
FDA

Seattle Genetics Announces FDA Approval of ADCETRIS® (Brentuximab Vedotin) in Combination with Chemotherapy for Adults with Previously Untreated Stage III or IV Classical Hodgkin Lymphoma

Seattle Genetics, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved ADCETRIS (brentuximab vedotin) in combination with chemotherapy in adult patients with previously untreated Stage III or IV classical Hodgkin lymphoma.

March 20, 2018
·
8 min read
FDA

Amerigen Pharmaceuticals Limited today announced that its Abbreviated New Drug Application for cyclophosphamide capsules 25mg and 50mg has received final approval from the U.S. Food and Drug Administration

Amerigen Pharmaceuticals Limited (“Amerigen”) today announced that its Abbreviated New Drug Application (“ANDA”) for cyclophosphamide capsules 25mg and 50mg has received final approval from the U.S. Food and Drug Administration.

March 20, 2018
·
1 min read
Biotech Beach

Advanced Bifurcation Systems Announces Plans for Asian Expansion

Advanced Bifurcation Systems (ABS), a medical stenting technology company, today announced plans to increase their footprint in Asian markets through partnerships in the region.

March 20, 2018
·
2 min read
FDA

FDA expands approval of Adcetris for first-line treatment of Stage III or IV classical Hodgkin lymphoma in combination with chemotherapy

The U.S. Food and Drug Administration today approved Adcetris to treat adult patients with previously untreated stage III or IV classical Hodgkin lymphoma (cHL) in combination with chemotherapy.

March 20, 2018
·
4 min read
Biotech Beach

Arena Pharmaceuticals Announces Proposed Public Offering of Common Stock

Arena Pharmaceuticals, Inc. announced that it intends to offer and sell, subject to market and other conditions, 7,500,000 shares of its common stock in an underwritten public offering.

March 20, 2018
·
2 min read